| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/2006 | EP1678205A1 Clq RELATED PROTEIN |
| 07/12/2006 | EP1678204A1 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 07/12/2006 | EP1678202A1 Hcv ns3-ns4a protease resistance mutants |
| 07/12/2006 | EP1678201A2 Hydrochloride salts of a glycopeptide phosphonate derivative |
| 07/12/2006 | EP1678200A2 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 07/12/2006 | EP1678199A2 Methods and compositions for mycoplasma pneumoniae exotoxins |
| 07/12/2006 | EP1678198A2 Side chain deuterated amino acids and methods of use |
| 07/12/2006 | EP1678197A2 Methods and compositions for pdgf-c activation and inhibition |
| 07/12/2006 | EP1678196A1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
| 07/12/2006 | EP1678195A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 07/12/2006 | EP1677875A1 A protein involved in ovarian cancer |
| 07/12/2006 | EP1677846A2 Bioactive hydrogel compositions for regenerating connective tissue |
| 07/12/2006 | EP1677842A2 Fibres embedded in a glassy protein |
| 07/12/2006 | EP1677833A2 In vivo gene therapy of parkinson's disease |
| 07/12/2006 | EP1677831A1 Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |
| 07/12/2006 | EP1677830A2 Antagonists of the bradykinin b1 receptor |
| 07/12/2006 | EP1677827A2 Combinations for hcv treatment |
| 07/12/2006 | EP1677825A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 07/12/2006 | EP1677823A1 Botulinum toxin treatments of neurological and neuropsychiatric disorders |
| 07/12/2006 | EP1677819A1 Long-acting molecules in sustained release formulations |
| 07/12/2006 | EP1677818A1 Stable aqueous g-csf-containing compositions |
| 07/12/2006 | EP1677817A1 G-csf therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
| 07/12/2006 | EP1677816A1 Therapeutic method |
| 07/12/2006 | EP1677815A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization. |
| 07/12/2006 | EP1677814A1 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders |
| 07/12/2006 | EP1677813A1 Angiogenic peptides and uses thereof |
| 07/12/2006 | EP1677812A2 Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
| 07/12/2006 | EP1677808A1 Combined preparation for treating sepsis |
| 07/12/2006 | EP1677754A1 Methods and compositions for treating erectile dysfunction |
| 07/12/2006 | EP1677751A1 Composition for treating bad breath |
| 07/12/2006 | EP1677744A2 Compositions and methods for treatment of muscle pain and muscle wasting |
| 07/12/2006 | EP1677737A2 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 07/12/2006 | EP1677735A2 Methods and compositions for modulating adipocyte function |
| 07/12/2006 | EP1677734A2 Cystatin c as an antagonist of tgf-b and methods related thereto |
| 07/12/2006 | EP1677597A2 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes |
| 07/12/2006 | EP1534749A4 Variant integrin polypeptides and uses thereof |
| 07/12/2006 | EP1509239A4 Composition and method for reducing post-prandial blood glucose |
| 07/12/2006 | EP1506225B1 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 07/12/2006 | EP1467750B1 Orodispersible pharmaceutical composition comprising perindopril |
| 07/12/2006 | EP1436321B1 Synthesis of cyclosporin analogs |
| 07/12/2006 | EP1338604B1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
| 07/12/2006 | EP1311286B1 Treatment of hepatitis c with thymosin and pegylated interferon |
| 07/12/2006 | EP1254253B1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 07/12/2006 | EP1237559B1 Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran |
| 07/12/2006 | EP1176976B1 Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women |
| 07/12/2006 | EP1150570B1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 07/12/2006 | EP1121439B1 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2006 | EP1121157B1 A novel component in the hedgehog signalling pathway |
| 07/12/2006 | EP1071764B1 Antisense oligonucleotides for the inhibition of integrin alphav-subunit expression |
| 07/12/2006 | EP1012178B1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
| 07/12/2006 | EP0994719B1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 07/12/2006 | EP0981540B1 A novel strain of bacillus for controlling plant diseases and corn rootworm |
| 07/12/2006 | EP0971743B1 Stabilized medicaments containing cysteinyl derivatives |
| 07/12/2006 | EP0970114B1 Neoglycoproteins |
| 07/12/2006 | EP0900235B1 Fragments of cr1 and their use |
| 07/12/2006 | EP0876396B1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 07/12/2006 | EP0869808B1 Use of glu-trp dipeptides for the manufacture of a medicament for the treatment of different conditions involving neovascularization |
| 07/12/2006 | EP0756488B1 Detection of alterations of tumor suppressor genes for the diagnosis of cancer |
| 07/12/2006 | CN1802437A Method for extracting collagen comprising microbial fermentation |
| 07/12/2006 | CN1802386A GLP-1 analog fusion plroteins |
| 07/12/2006 | CN1802385A Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity |
| 07/12/2006 | CN1802384A Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 07/12/2006 | CN1802172A Therapeutic composition for autoimmune conditions |
| 07/12/2006 | CN1802171A Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| 07/12/2006 | CN1802170A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 07/12/2006 | CN1802169A Use of bv8 and/or EG-VEGF to promote hematopoiesis |
| 07/12/2006 | CN1802168A Sigma ligands for neuronal regeneration and functional recovery |
| 07/12/2006 | CN1802167A Fusion proteins |
| 07/12/2006 | CN1802166A Compositions for mucosal and oral administration comprising HCG fragments |
| 07/12/2006 | CN1802152A Improved treatment of cancer with glutamine |
| 07/12/2006 | CN1802093A Composition with heart rate reducing properties |
| 07/12/2006 | CN1800399A 磷酸二酯酶8a Phosphodiesterase 8a |
| 07/12/2006 | CN1800389A Chlamys Farreri H2A gene clone and N terminal expression technology |
| 07/12/2006 | CN1800385A Hybrid expression of neisserial proteins |
| 07/12/2006 | CN1800382A Recombinant human hepassocin preparation method and its uses in preparing medicine for anti-liver injury |
| 07/12/2006 | CN1800215A Related gene and protein for preventing and treating Japanese blood fluke infection, and its uses |
| 07/12/2006 | CN1800213A Peptides |
| 07/12/2006 | CN1800210A Compounds for treatment of infectious and immune system disorders and methods for their use |
| 07/12/2006 | CN1799631A Animal model for fetal alcohol syndrome and methods of treatment |
| 07/12/2006 | CN1799629A Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
| 07/12/2006 | CN1799628A Mixed heat shock protein/peptide sarcoma vaccine and its preparation method |
| 07/12/2006 | CN1799627A Natto kinase oral liquid and its manufacturing method |
| 07/12/2006 | CN1799626A Recombined human interferon-gamma liposome gel and its application in treatment of condyloma acuminatum |
| 07/12/2006 | CN1799625A Preparation of officinal interleukin |
| 07/12/2006 | CN1799624A chromatin peptide for blocking human HIF-1 alpha gene and regulating network downstream related gene |
| 07/12/2006 | CN1799623A Use of No. 21 biological active peptide in preparation of medicine for preventing and treating arthritis |
| 07/12/2006 | CN1799378A Human colostrum-simulated biological milk powder |
| 07/12/2006 | CN1263864C Recombinant adenoviral vector and methods of use |
| 07/12/2006 | CN1263856C Operation of enzymatic vitality of protoporphyrinogen oxidase in eukaryote |
| 07/12/2006 | CN1263854C Neisserial antigens |
| 07/12/2006 | CN1263853C Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 07/12/2006 | CN1263852C Extracellular matrix signalling molecules |
| 07/12/2006 | CN1263771C Preparing method and use for osteoprotegerin fusion protein |
| 07/12/2006 | CN1263770C Novel peptides and medicinal uses thereof |
| 07/12/2006 | CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses |
| 07/12/2006 | CN1263510C Polysaccharide protein conjugate or oligosaccharide-protein conjugate, preparation method and application thereof |
| 07/12/2006 | CN1263507C APRIL receptor (BCMA) and uses thereof |
| 07/12/2006 | CN1263506C Application of laevorotation carnosine in preparation of medication for assistant treatment of hepatitis and healthy foods |
| 07/12/2006 | CN1263476C Poisonous element content-decreasing Kawa extracts and its composition and preparing method |
| 07/12/2006 | CN1263465C Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of anyloid A beta peptide |